- Home
- CART vs EXEL Comparison
CART vs EXEL Comparison
Compare CART & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CART
- EXEL
- Stock Information
- Founded
- CART 2012
- EXEL 1994
- Country
- CART United States
- EXEL United States
- Employees
- CART N/A
- EXEL N/A
- Industry
- CART
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CART
- EXEL Health Care
- Exchange
- CART Nasdaq
- EXEL Nasdaq
- Market Cap
- CART 11.4B
- EXEL 10.0B
- IPO Year
- CART 2023
- EXEL 2000
- Fundamental
- Price
- CART $42.76
- EXEL $34.59
- Analyst Decision
- CART Buy
- EXEL Buy
- Analyst Count
- CART 25
- EXEL 17
- Target Price
- CART $48.40
- EXEL $32.18
- AVG Volume (30 Days)
- CART 4.0M
- EXEL 1.7M
- Earning Date
- CART 02-11-2025
- EXEL 02-04-2025
- Dividend Yield
- CART N/A
- EXEL N/A
- EPS Growth
- CART N/A
- EXEL 441.02
- EPS
- CART 1.53
- EXEL 1.55
- Revenue
- CART $3,298,000,000.00
- EXEL $2,081,598,000.00
- Revenue This Year
- CART $13.48
- EXEL $20.59
- Revenue Next Year
- CART $8.95
- EXEL $1.50
- P/E Ratio
- CART $27.91
- EXEL $22.41
- Revenue Growth
- CART 10.08
- EXEL 17.31
- 52 Week Low
- CART $22.13
- EXEL $19.20
- 52 Week High
- CART $50.01
- EXEL $36.97
- Technical
- Relative Strength Index (RSI)
- CART 48.81
- EXEL 51.61
- Support Level
- CART $40.88
- EXEL $34.30
- Resistance Level
- CART $44.41
- EXEL $36.22
- Average True Range (ATR)
- CART 1.40
- EXEL 0.75
- MACD
- CART -0.08
- EXEL -0.29
- Stochastic Oscillator
- CART 41.27
- EXEL 25.09
About CART Maplebear Inc.
Maplebear (Instacart) operates a leading grocery delivery platform in the United States and Canada. The company partners with various regional and national grocers, which offer their selection of food and other goods to customers through Instacart's ubiquitous platform. Once an item is ordered through Instacart's site, the item is picked and delivered to the customer's home by one of the platform's 600,000 shoppers, who are classified as independent contractors. Instacart earns fees based on average order value and leverages its platform's high usage to sell advertising, mainly to consumer-packaged goods companies. Instacart currently has about 8 million monthly active users (or orderers) on its platform.
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.